Gene name | SNP | Control (n = 192) | Non-severe (n = 89) | Severe (n = 93) |
---|---|---|---|---|
ICAM1 | Ex6 (rs5498) | Â | Â | Â |
 | AA | 70 (36.5%) | 17 (19.1%) | 21 (22.5%) |
 | AG | 93 (48.4%) | 46 (51.7%) | 42 (45.2%) |
 | GG | 29 (15.1%) | 26 (29.2%) | 30 (32.3%) |
PECAM1 | Ex3 (rs668) | Â | Â | Â |
 | CC | 108 (56.3%) | 39 (43.8%) | 43 (46.2%) |
 | CG | 53 (27.6%) | 36 (40.4%) | 40 (43%) |
 | GG | 31 (16.1) | 14 (15.7%) | 10 (10.8%) |
 | Ex8 (rs12953) |  |  |  |
 | GG | 80 (41.7%) | 30 (33.7%) | 40 (43%) |
 | AG | 76 (39.5) | 40 (44.9%) | 32 (34.4%) |
 | AA | 36 (18.8%) | 19 (21.3%) | 21 (22.6%) |
 | Ex12 (rs1131012) |  |  |  |
 | AA | 69 (35.9%) | 28 (31.4%) | 41 (44.1%) |
 | AG | 101 (52.6%) | 43 (48.3%) | 34 (36.6%) |
 | GG | 22 (11.5%) | 18 (20.2%) | 18 (19.3%) |
CD36 | -14 (rs2151916) | Â | Â | Â |
 | TT | 83 (43.2%) | 31 (34.8%) | 38 (40.9%) |
 | TC | 76 (39.6%) | 42 (47.2%) | 38 (40.9%) |
 | CC | 33 (17.2%) | 16 (18%) | 17 (18.2%) |
 | -53 (rs1334512) |  |  |  |
 | GG | 61 (31.8%) | 34 (38.2%) | 47 (50.5%) |
 | GT | 87 (45.3%) | 36 (40.4%) | 32 (34.4%) |
 | TT | 44 (22.9%) | 19 (21.3%) | 14 (15.1%) |
 | Ex1a |  |  |  |
 | TT | 115 (59.9%) | 42 (47.2%) | 38 (40.9%) |
 | TA | 59 (30.7%) | 32 (36%) | 30 (32.2%) |
 | AA | 18 (9.4%) | 15 (16.8%) | 25 (26.9%) |